post-market monitoring

Highly qualified experts & technology to ensure continued commercial safety and access.

image (4)-1

 

Although preclinical trials provide important information regarding safety and effectiveness, it is possible that new safety concerns will emerge. As a result, health authorities continue to monitor performance after approval. ProPharma’s expertise spans across the following Post-Market competencies:

  • Market Development and Commercial Readiness
  • Patient Reported Safety & Outcomes
  • Real World Evidence
  • Labeling & Promotional Review
  • Risk Management Plans

 

 

Colorized half circle.

Post-Market Monitoring

Real world and observational studies to support long term drug evaluation and integrated marketed product maintenance activities for continued commercial differentiation, safety, and access.

Patient Reported Safety and Outcomes

Adverse Event (AE) Intake and Follow-up Services

Our skilled staff follows established processes and guidelines to obtain timely, accurate, and comprehensive adverse event information. All AE data is thoroughly documented in either our fully validated database or your MI database, and AE case records are sent to the designated pharmacovigilance (PV) department within one business day. Our experienced MI team is also fully equipped to execute outbound follow-up communication, to collect additional data that was not available at initial intake and lessen the burden on your pharmacovigilance department. For a seamless experience, ProPharma offers comprehensive AE processing and reporting through our dedicated pharmacovigilance team to supplement or fully outsource your existing PV function.

 

 

Adverse Intake and Followup

 

Product Complaint Intake and Follow-up Services

As your trusted MI partner, our highly trained staff follow established processes and guidelines for handling PQC events, to meet both regulatory reporting requirements as well as your company’s own internal quality and manufacturing standards. Our experts can conduct case follow-ups and/or provide full case processing on your company’s behalf. We are dedicated to supporting your customers and patients, beyond just satisfying regulations.

Talk with an Expert

Real World Evidence

ProPharma's team of experts support Real World Evidence (RWE) research efforts so that clients can make faster decisions and have better insight into their products and meet key stakeholder needs.

Our team takes a customized approach to RWE that assesses each client's specific needs and develops strategic solutions that support their asset leading up to commercial launch and beyond.

Real World Evidence_1020878011

 

RWE services include:

  • Non-Interventional Studies
    • Registries (product, indication)
    • Database driven (EMR, etc.)
  • Systematic and targeted literature reviews
    • Data Dissemination/Publications
  • Synthesis and Modeling
    • Economic Modeling
    • Dossier and Submission Support

Labelling & Promotional Review

Compelling, Compliant Information to Successfully Promote Your Product

Any activity undertaken, organized, or sponsored by a company that is intended to promote the prescription, recommendation, supply, administration, or consumption of a pharmaceutical, biotechnology, or medical device product may be considered promotional material. Such marketing collateral can be available through various methods of communication, including ads and brochures, mailings, websites, congress materials, and presentations from spokespersons or medical representatives. This content must follow strict European Union (EU) and national guidelines relating to the promotion of medicines, such as the European Federation of Pharmaceutical Industries and Associations (EFPIA) code of practice.

During every step of the product lifecycle, your product’s messaging to healthcare professionals and patients must always be clear, compelling, and fully compliant. Whether you’re developing print materials, websites, digital sales aids, or patient support materials, ProPharma has the knowledge and experience to help ensure all of your marketing materials are balanced and aligned with all regulatory and ethical codes.

Talk with an Expert

Fair Balance, Compliance, and Business Objectives

Promotional material has two equally important objectives:

(1) it must achieve business goals, and (2) it must comply with regulatory constraints. Any promotional material must always accurately present both risks and benefits, and all claims need to be truthful, substantiated, and non-misleading.
At ProPharma, our experts can ensure that you adhere to applicable laws, regulations, and industry standards while maintaining the highest ethical standards for reporting of your sales, marketing, and promotional material in the EU/European Economic Area (EEA). We can help with all aspects of creating and publishing promotional material, including:

  • Regulatory review of promotional and non-promotional materials and activities in accordance with the respective ethical codes in the local country
  • Creation and update of Abbreviated Product Information (API) texts
  • Support in setting up a routine for local review of promotional materials in the local country
  • Advice on general questions regarding the local ethical codes

Medical & Regulatory Advertising Promotional Review

ProPharma provides medical and regulatory review services with our experienced staff that are overseen and mentored by leaders who have sat in your chair:

 

  • Service provider in over 100 companies of all shapes and sizes
  • Experience in pharmaceutical, biotechnology, medical device (Class I, II, III), nutritional supplements, animal health and cosmetic products
  • Collaborative professionals who launch new products (pre-approval, launch and post-approval brand support), maintain growth and legacy products
    • Promotional Materials - HCP, Consumer and Managed Care
    • Press/Public Affairs Materials and Activities
    • Medical Affairs/R&D Materials

Regulatory Review

Experienced and collaborative regulatory professionals.
  • OPDP or APLB product advisory comment submissions –authoring, editing, and preparation
  • Successful interactions with OPDP
  • Guide teams through FDA regulations, guidance documents and enforcement communications
  • Deep understanding of trial design and outcomes

Medical Review

Cost-effective resources to manage day-to-day review responsibilities, without sacrificing scientific accuracy or integrity.

  • Promotional and Medical Review Committee participation
  • Medical accuracy and evidentiary standard review (substantial evidence, competent and reliable/FTC)
  • Broad therapeutic experience

Labeling Development  

The ProPharma team includes experienced staff to help companies develop HCP and consumer labeling for prescription drugs and biologics.  

ProPharma provides strategic support to your team. Our experienced staff can manage the entire product labeling process, including development of:

  • Company Core Data Sheets (CCDS)
  • U.S. package inserts
  • Medication guides
  • E.U. Summary of Product Characteristics (SPC)
  • Patient Information Leaflets (PIL)

Develop labeling content, manage and support complex labeling and regulatory situations, manage health authority communications, and assist in the design of your company’s labeling policy and process - that's what we do at ProPharma.

Talk with an Expert

Labeling

Compliance Program Development & Monitoring

ProPharma helps companies develop and maintain effective compliance programs. Monitoring and Auditing Support. The compliance monitoring program at ProPharma includes:

  • Field monitoring:  ride-alongs, speaker programs and other events
  • Monitoring of data analytics from sales representatives, HCP interactions, and email Strategic monitoring plans such as quick start guides and plans for protocol development

Compliance Program Development

ProPharma helps small companies develop ethics and compliance programs using the Office of the Inspector General’s seven elements of an effective compliance program as a starting point and then develop programs to meet state and federal compliance requirements to avoid unwanted scrutiny, enforcement, and fines. To make that happen, we implement our proprietary four-step process:

  • Perform program assessment
  • Identify and document inherent compliance risks
  • Compliance program development 
  • Compliance monitoring and support

Talk with an Expert

Regulatory Operations

ProPharma helps companies implement the correct solutions of processes, standards, systems, templates, and best practices for effective Regulatory Operations. With the right Regulatory Operations group, you can achieve high quality document management, data management, and regulatory agency submissions.

ProPharma provides strategic support to your team.  Our experienced staff can assist with:

  • Process Optimization
  • System Implementations
  • Document Management
  • Submission Management
  • Publishing
  • Archiving
  • RIM
  • Submission Managers
  • Publishers
  • Fully Outsourced Regulatory Operations

Marketing Operations

Promotional Material Review Process & Marketing Materials Management 

  • Commercial Operations Infrastructure Build & Support (Policy, Process, and Procedure Development)
  • Promotional Material "Medical, Legal, Regulatory (MLR)" Review Process Management
  • Technical System Implementation (Veeva/PromoMats)
  • Marketing Materials Execution Project Management (Print & Digital Production and Distribution)
  • HCP & Patient Speaker Bureau and Speaker Program Operations Management
  • Medical Conventions, Exhibits, Meetings & Events Management
  • Vendor/External Partner Procurement & Management
Talk with an Expert

News & Insights

5 Key Challenges in the Development of Gene Therapies

June 18, 2024

5 Key Challenges in the Development of Gene Therapies

Key challenges in gene therapy development include nonclinical efficacy, CDMO partner selection, payor pre-approval, clinical trial endpoints, and site selection.

An Overview of the PSMF: Pharmacovigilance System Master File

June 17, 2024

An Overview of the PSMF: Pharmacovigilance System Master File

Learn about the Pharmacovigilance System Master File (PSMF) in the EU, its history, structure, updates, and outsourcing options.

The GPO An Essential Guide to the Graduated Plan Officer (Der Stufenplanbeauftragte)

June 13, 2024

The GPO An Essential Guide to the Graduated Plan Officer (Der Stufenplanbeauftragte)

Read ProPharma's essential guide to the Graduated Plan Officer (GPO), outlining requirements, responsibilities, and local registration processes.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

May 2, 2024

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

ProPharma and PBL introduce Cell Factory Box for decentralized Cell & Gene Therapies manufacturing, reducing costs and improving patient access to life-saving treatments.

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

April 18, 2024

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

ProPharma receives Medidata Rave EDC accreditation, enhancing clinical trial efficiency. Learn about the latest milestone delivering cutting-edge solutions.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

October 11, 2023

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

Everest Group has recognized ProPharma Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023.

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

May 2, 2024

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

ProPharma and PBL introduce Cell Factory Box for decentralized Cell & Gene Therapies manufacturing, reducing costs and improving patient access to life-saving treatments.

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

April 18, 2024

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

ProPharma receives Medidata Rave EDC accreditation, enhancing clinical trial efficiency. Learn about the latest milestone delivering cutting-edge solutions.

Previous Post Arrow Next Post Arrow
ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

October 11, 2023

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

Everest Group has recognized ProPharma Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023.

Previous Award Arrow Next Award Arrow
5 Key Challenges in the Development of Gene Therapies

June 18, 2024

5 Key Challenges in the Development of Gene Therapies

Key challenges in gene therapy development include nonclinical efficacy, CDMO partner selection, payor pre-approval, clinical trial endpoints, and site selection.

An Overview of the PSMF: Pharmacovigilance System Master File

June 17, 2024

An Overview of the PSMF: Pharmacovigilance System Master File

Learn about the Pharmacovigilance System Master File (PSMF) in the EU, its history, structure, updates, and outsourcing options.

The GPO An Essential Guide to the Graduated Plan Officer (Der Stufenplanbeauftragte)

June 13, 2024

The GPO An Essential Guide to the Graduated Plan Officer (Der Stufenplanbeauftragte)

Read ProPharma's essential guide to the Graduated Plan Officer (GPO), outlining requirements, responsibilities, and local registration processes.

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow

Complex Needs Require Custom Solutions

ProPharma builds solutions at the intersection of innovation and flexibility. We’re here to offer a custom alternative that fits your unique needs. Standout solutions scaled to your size.